JPRN-UMIN000010498已完成未知
Prognostic Value of Dual-time-point 18F-FDG PET in Fibrotic Idiopathic Interstitial Pneumonia - Prognostic Value of Dual-time-point 18F-FDG PET in Fibrotic Idiopathic Interstitial Pneumonia
Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui0 个研究点目标入组 80 人开始时间: 2013年4月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with defined connective tissue disease, left ventricular failure, occupational and/or environmental exposure that resulted in interstitial pneumonia, or history of ingestion of a drug or agent known to cause pulmonary fibrosis were excluded from the study.
研究者
相似试验
已完成
不适用
Dual-time-point 18F-FDG PET Imaging for Predicting Treatment Response in Patients with Interstitial PneumoniaInterstitial pneumoniaJPRN-UMIN000009826Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui40
已完成
不适用
The Prognostic Value of 18F-FDG PET/CT Taken Immediately After Completion of Radiotherapy for Lung Cancer Treated with Concurrent Chemoradiotherapy: A Pilot Studyung cancerJPRN-UMIN000037493Juntendo University Faculty of Medicine19
尚未招募
Unknown
The Prognostic Value of 18F-FDG PET/CT Taken Immediately After Completion of Radiotherapy for Lung Cancer Treated with Concurrent Chemoradiotherapy: Comparison between PET/CT taken after completion of adjuvant Durvalumabnon small cell lung cancerJPRN-UMIN000050438Juntendo University Faculty of Medicine Urayasu Hospital36
已完成
不适用
The predictive value of 18F-FDG-PET to demonstrate disease activity in patients with relapsed multiple myeloma; a pilot studyKahler's disease10018865NL-OMON32803niversitair Medisch Centrum Groningen15
已完成
不适用
Evaluation of early prediction using 18F-FDG PET/CT for patients with Iodine-131 refractory differentiated thyroid carcinoma treated with lenvatinibdifferentiated thyroid carcinomaJPRN-UMIN000022592Department of Medical Oncology, Hokkaido University Graduate School of Medicine22